Related references
Note: Only part of the references are listed.A High Frequency of Activating Extracellular Domain ERBB2 (HER2) Mutation in Micropapillary Urothelial Carcinoma
Jeffrey S. Ross et al.
CLINICAL CANCER RESEARCH (2014)
BK virus-associated urinary bladder carcinoma in transplant recipients: report of 2 cases, review of the literature, and proposed pathogenetic model
Borislav A. Alexiev et al.
HUMAN PATHOLOGY (2013)
Association of micropapillary urothelial carcinoma of the bladder and BK viruria in kidney transplant recipients
S. Bialasiewicz et al.
TRANSPLANT INFECTIOUS DISEASE (2013)
Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer
Ron Bose et al.
CANCER DISCOVERY (2013)
Treating Breast Cancer in the 21st Century: Emerging Biological Therapies
Gabriel Tinoco et al.
JOURNAL OF CANCER (2013)
Targeted Therapy for Gastric Cancer
Elizabeth C. Smyth et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2012)
HER2 Overexpression Elicits a Proinflammatory IL-6 Autocrine Signaling Loop That Is Critical for Tumorigenesis
Zachary C. Hartman et al.
CANCER RESEARCH (2011)
Her2 Amplification is Significantly More Frequent in Lymph Node Metastases From Urothelial Bladder Cancer Than in the Primary Tumours
Achim Fleischmann et al.
EUROPEAN UROLOGY (2011)
HER2 gene amplification occurs frequently in the micropapillary variant of urothelial carcinoma: analysis by dual-color in situ hybridization
Christina B. Ching et al.
MODERN PATHOLOGY (2011)
Assessing HER2 gene amplification as a potential target for therapy in invasive urothelial bladder cancer with a standardized methodology: results in 1005 patients
M. Lae et al.
ANNALS OF ONCOLOGY (2010)
Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: Biologic and Methodologic Considerations
Guido Sauter et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
HER2 overexpression and amplification in urothelial carcinoma of the bladder is associated with MYC coamplification in a subset of cases
Donna E. Hansel et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
No strong association between HER-2/neu protein overexpression and gene amplification in high-grade invasive urothelial carcinomas
Vildan Caner et al.
PATHOLOGY & ONCOLOGY RESEARCH (2008)
Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: A population-based study
Mark A. Jenkins et al.
GASTROENTEROLOGY (2007)
Morphological features of TMPRSS2-ERG gene fusion prostate cancer
J-M Mosquera et al.
JOURNAL OF PATHOLOGY (2007)
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Mutational analysis of the HER2 gene in lung tumors from Caucasian patients:: Mutations are mainly present in adenocarcinomas with bronchioloalveolar features
Fiamma Buttitta et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy
X-F Wen et al.
ONCOGENE (2006)
Somatic mutations of the HER2 kinase domain in lung adenocarcinomas
H Shigematsu et al.
CANCER RESEARCH (2005)
Her-2/neu protein overexpression and gene amplification in human transitional cell carcinoma of the bladder
CL Coogan et al.
UROLOGY (2004)
Intragenic ERBB2 kinase mutations in tumours
P Stephens et al.
NATURE (2004)
HER2/neu gene amplification and protein overexpression in G3 pT2 transitional cell carcinoma of the bladder: a role for anti-HER2 therapy?
Z Latif et al.
EUROPEAN JOURNAL OF CANCER (2004)
HER-2 and TOP2A coamplification in urinary bladder cancer
R Simon et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Receptor tyrosine kinase signalling as a target for cancer intervention strategies
E Zwick et al.
ENDOCRINE-RELATED CANCER (2001)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Share Paper
